Olema Pharmaceuticals, Inc. - OLMA

SEC FilingsOur OLMA Tweets

About Gravity Analytica

Recent News

  • 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.03.2025 - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.03.2025 - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 05.28.2025 - Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
  • 05.28.2025 - Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
  • 05.27.2025 - T.D. Cowen 6th Annual Oncology Innovation Summit
  • 05.27.2025 - T.D. Cowen 6th Annual Oncology Innovation Summit

Recent Filings

  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors